Nectero Therapeutics is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients’ lives
Nectero Therapeutics is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients’ lives. The company is developing an investigational treatment with the potential to stabilize growth and minimize risk of rupture of small to mid-sized abdominal aortic aneurysms (AAA) using an endovascular approach.